ℹ️
🇬🇧
Search
Search for publications relevant for "hormone-refractory"
hormone-refractory
Publication
Class
Person
Publication
Programmes
publication
Interdisciplinary communication between urologist and oncologist and its implementation in hormone refractory prostate cancer
2009 |
First Faculty of Medicine
publication
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
2005 |
Publication without faculty affiliation
publication
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
2005 |
First Faculty of Medicine
publication
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer
2003 |
First Faculty of Medicine
publication
Chemohormonal regimen of epirubicin, etoposide, and dexamethasone in patients with hormone-refractory prostate cancer
2003 |
First Faculty of Medicine
publication
The Treatment of Hormone Refractory Metastatic Carcinoma of the Prostate
2001 |
Faculty of Medicine in Hradec Králové
publication
Is it reasonable to consider second-line chemotherapy in patients with hormone-refractory prostate cancer?
+1
2005 |
Faculty of Medicine in Hradec Králové
publication
FOCUS on FOCIS: Combined chemo-immunotherapy for the treatment of hormone-refractory metastatic prostate cancer
2009 |
First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
publication
Chemohormonal regimen of epirubicin, etoposide, and dexamethasone in patients with hormone-refractory prostate cancer
2003 |
Faculty of Medicine in Hradec Králové
publication
Bi-weekly epirubicin, etoposide and low-dose dexamethasone for hormone-refractory prostate cancer
2003 |
Faculty of Medicine in Hradec Králové
publication
Prospective Evaluation of Samarium-153-EDTMP Radionuclide Treatment for Bone Metastases in Patients with Hormone-refractory Prostate Cancer
2007 |
Publication without faculty affiliation
publication
Bi.weekly eipirubicin and etoposide plus low dose dexamethasone (EED) for hormone-refractory prostate cancer (HRPC)
Publication without faculty affiliation
publication
Chemohormonal therapy using EED regimen (Epirubicin, Etoposide, Dexamethason) in patients with hormonal-refractory prostate cancer
2001 |
Faculty of Medicine in Hradec Králové
publication
Palliative radionuclide therapy for painful bone metastases in patients with prostate cancer
+1
2008 |
Publication without faculty affiliation
publication
Palliative radionuclide therapy for painful bone metastases in patients with prostate cancer
2008 |
First Faculty of Medicine
publication
Palliative radionuclide therapy for painful bone metastases by means of 186Rhenium-HEDP
2011 |
Faculty of Medicine in Hradec Králové
publication
CD4(+) T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein
2021 |
Second Faculty of Medicine
publication
Personalized ex vivo multiple peptide enrichment and detection of T cells reactive to multiple tumor-associated antigens in prostate cancer patients
2017 |
Second Faculty of Medicine